Qvents

Qvents

Discussion forum for Pharma Quality events, Regulatory Actions

Qvents Qvents
  • Home 
    • About Us 
    • Contact Us 
    • Expert Panel 
    • Tags 
  • Qvents 
    • Warning Letters 
    • 483s 
    • Recalls 
    • Import Alerts 
    • Quality Insights 
    • Tags 
  • Forums 
  • Learning Resources 
    • Upcoming Trainings 
    • Training Archives 
  • Guidelines 
  • Pharma Jobs 
    • Job Openings 
    • Post a Job
      • Jobs posted by me 
  • Users & Profiles 
  • News 
  • Login/Register
    • Individual
    • Company
Qvents Qvents
Qvents
  • Home 
    • About Us 
    • Contact Us 
    • Expert Panel 
    • Tags 
  • Qvents 
    • Warning Letters 
    • 483s 
    • Recalls 
    • Import Alerts 
    • Quality Insights 
    • Tags 
  • Forums 
  • Learning Resources 
    • Upcoming Trainings 
    • Training Archives 
  • Guidelines 
  • Pharma Jobs 
    • Job Openings 
    • Post a Job
      • Jobs posted by me 
  • Users & Profiles 
  • News 
  • Login/Register
shape
shape
shape
shape

Tag: Andrew W Evenson

Sichuan Deebio – 483, OAI and Warning

Chinese API Manufacturer Sichuan Deebio Pharmaceuticals was awarded USFDA 483 with six observations citing Data

Qvents
March 8, 2024
  • Facebook
  • LinkedIn
  • Twitter

Search Posts

Latest Posts

Glenmark Warning Letter Cites 21 CFR 211.192 Violations at Multiple Sites
August 7, 2025
Natco Pharma USFDA 483 Flags Deficiencies in Aseptic Areas, Validation
August 2, 2025
Loss of Potency: Accord / Intas Recall Hypothyroidism / Thyroxine Drug
July 25, 2025
Nitrosamine Impurities in Pharmaceutical Products: Templates for Risk Assessment and Supplier Evaluation
June 28, 2025
Supply Chain Traceability of Medicinal Products
May 31, 2025
footer shape 1
footer shape 2
 Quick Links 
  • Forums
  • Warning Letters
  • 483s
  • Recalls
  • Import Alerts
  • Quality Insights
 
  • News
  • Guidelines
  • Pharma Jobs
  • Job Openings
  • Post a Job
 
  • Users & Profiles
  • Trainings and Webinar
  • About Us
  • Contact Us
  • Facebook
  • LinkedIn
  • Twitter

© 2023 All Rights Reserved by Qvents

  • Terms and Conditions
  • Privacy Policy